ENTITY
Abbott India

Abbott India (BOOT IN)

66
Analysis
Health Care • India
Abbott India Limited is a publicly listed subsidiary of Abbott Laboratories, operating as a significant pharmaceutical company in India. It develops, manufactures, and markets science-based healthcare products across various therapeutic areas, including women's health, gastroenterology, metabolics, central nervous system, and vaccines. The company was incorporated on August 22, 1944, and is headquartered in Mumbai, Maharashtra, India.
more
•27 May 2021 09:12

India: Stock Reclassification & Active Portfolio Management

There are a lot of segment changes expected in July when AMFI recategorizes stocks and mutual funds start to rebalance their portfolios. We...

Logo
548 Views
Share
bullish•SBI Card
•02 Jul 2020 09:58

India Stock Classification Changes - Active Portfolio Churn

Once up a time in India, there was a smorgasbord of mutual fund schemes launched by different fund houses. The same fund house had myriad schemes...

Logo
734 Views
Share
bullish•Piramal Enterprises
•08 Apr 2020 14:15

TPG and KKR in Race to Buy 20% Stake in Piramal’s Pharma Business Valued Over US$2bn

It was reported by several news media outlets that the US PE giants, TPG Capital or KKR may acquire a 20% stake in India’s Piramal Enterprises...

Share
bearish•Eris Lifesciences
•17 Jun 2017 09:12

Eris Lifesciences IPO - Rich Valuations at What Appears to Be Unsustainably High Margins

Eris Lifesciences plans to raise US$270m in its IPO through a selldown of shares by a ChrysCapital, a PE investor, and the founders. Our fellow...

Logo
575 Views
Share
x